Patent ID: 7544684

Claim:
A method C) for controlling an allergic disease, asthma, chronic bronchitis, atopic dermatitis, psoriasis, rheumatoid arthritis, multiple sclerosis, Crohn's disease, diabetes mellitus, ulcerative colitis, osteoporosis, transplant rejection reactions, cachexia, sepsis, atherosclerosis or AIDS; comprising administering to a patient in need thereof an effective amount of a compound of formula I in which R 1 , R 2 in each case independently of one another are H, OH, OR 5 , —SR 5 , —SOR 5 , —SO 2 R 5 Hal, R 1 R 2 together are also —OCH 2 O— or —OCH 2 CH 2 O—, R 3 , R 3 in each case independently of one another are H, R 5 , OH, OR 5 , NH 2 , NHR 5 , NAA′, NHCOR 5 , NHCOOR 5 , Hal, COOH, COOR 5 , CONH 2 , CONHR 5 or CONR 5 A′, R 4 is CN or R 5 is A or cycloalkyl with 3 to 6 C-atoms, which can be substituted by 1 to 5 F and/or Cl atoms, or —(CH 2 ) n —Ar, A, A′ in each case independently of one another are alkyl with 1 to 10 C-atoms or are alkenyl with 2 to 8 C-atoms, which can be substituted by 1 to 5 F and/or Cl atoms, A and A′ together are alternatively cycloalkyl or cycloalkylene with 3 to 7 C-atoms, wherein one CH 2 group can be replaced by O , NH, NA, NCOA or NCOOA, Ar is phenyl, is 0, 1 or 2, Hal is F, Cl, Br or I or a pharmaceutically acceptable salt, or a stereoisomer thereof.